TITLE

Enfuvirtide Added to an Optimized Antiretroviral Regimen Provided Significant Benefits in Patients with Multidrug-Resistant HIV Infection

AUTHOR(S)
Lorber, Bennett
PUB. DATE
December 2004
SOURCE
Annals of Internal Medicine;12/7/2004, Vol. 141 Issue 11, p877
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on papers related to infectious diseases in the U.S. The paper "Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America," by J.P. Lalezari, K. Henry, M. O'Hearn et al. studied that enfuvirtide added to an optimized antiretroviral regimen provided significant benefits in patients with multidrug-resistant HIV infection. This randomized, open-label, phase 3 study of enfuvirtide involved 501 patients from 48 sites in the United States, Canada, Mexico and Brazil.
ACCESSION #
15279606

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics